Zobrazeno 1 - 10 of 15 pro vyhledávání: '"Wells RC"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier.
Autor: Barker SJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Thayer MB; Denali Therapeutics Inc., South San Francisco, CA, USA., Kim C; Denali Therapeutics Inc., South San Francisco, CA, USA., Tatarakis D; Denali Therapeutics Inc., South San Francisco, CA, USA., Simon MJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Dial R; Denali Therapeutics Inc., South San Francisco, CA, USA., Nilewski L; Denali Therapeutics Inc., South San Francisco, CA, USA., Wells RC; Denali Therapeutics Inc., South San Francisco, CA, USA., Zhou Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Afetian M; Ionis Pharmaceuticals, Carlsbad, CA, USA., Akkapeddi P; Denali Therapeutics Inc., South San Francisco, CA, USA., Chappell A; Ionis Pharmaceuticals, Carlsbad, CA, USA., Chew KS; Denali Therapeutics Inc., South San Francisco, CA, USA., Chow J; Denali Therapeutics Inc., South San Francisco, CA, USA., Clemens A; Denali Therapeutics Inc., South San Francisco, CA, USA., Discenza CB; Denali Therapeutics Inc., South San Francisco, CA, USA., Dugas JC; Denali Therapeutics Inc., South San Francisco, CA, USA., Dwyer C; Ionis Pharmaceuticals, Carlsbad, CA, USA., Earr T; Denali Therapeutics Inc., South San Francisco, CA, USA., Ha C; Denali Therapeutics Inc., South San Francisco, CA, USA., Ho YS; Denali Therapeutics Inc., South San Francisco, CA, USA., Huynh D; Denali Therapeutics Inc., South San Francisco, CA, USA., Lozano EI; Denali Therapeutics Inc., South San Francisco, CA, USA., Jayaraman S; Denali Therapeutics Inc., South San Francisco, CA, USA., Kwan W; Denali Therapeutics Inc., South San Francisco, CA, USA., Mahon C; Denali Therapeutics Inc., South San Francisco, CA, USA., Pizzo M; Denali Therapeutics Inc., South San Francisco, CA, USA., Robles-Colmenares Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Roche E; Denali Therapeutics Inc., South San Francisco, CA, USA., Sanders L; Denali Therapeutics Inc., South San Francisco, CA, USA., Stergioulis A; Denali Therapeutics Inc., South San Francisco, CA, USA., Tong R; Denali Therapeutics Inc., South San Francisco, CA, USA., Tran H; Denali Therapeutics Inc., South San Francisco, CA, USA., Zuchero Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Estrada AA; Denali Therapeutics Inc., South San Francisco, CA, USA., Gadkar K; Denali Therapeutics Inc., South San Francisco, CA, USA., Koth CMM; Denali Therapeutics Inc., South San Francisco, CA, USA., Sanchez PE; Denali Therapeutics Inc., South San Francisco, CA, USA., Thorne RG; Denali Therapeutics Inc., South San Francisco, CA, USA., Watts RJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Sandmann T; Denali Therapeutics Inc., South San Francisco, CA, USA., Kane LA; Denali Therapeutics Inc., South San Francisco, CA, USA., Rigo F; Ionis Pharmaceuticals, Carlsbad, CA, USA., Dennis MS; Denali Therapeutics Inc., South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA, USA., DeVos SL; Denali Therapeutics Inc., South San Francisco, CA, USA.
Publikováno v: Science translational medicine [Sci Transl Med] 2024 Aug 14; Vol. 16 (760), pp. eadi2245. Date of Electronic Publication: 2024 Aug 14.
Zobrazit plný text záznamu
5
Author Correction: CD98hc is a target for brain delivery of biotherapeutics.
Autor: Chew KS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Wells RC; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Moshkforoush A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chan D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lechtenberg KJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tran HL; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chow J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Kim DJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Robles-Colmenares Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Srivastava DB; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tong RK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tong M; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Xa K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Yang A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Zhou Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Akkapeddi P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Annamalai L; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Bajc K; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA., Blanchette M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA., Cherf GM; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Gill A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Huynh D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Joy D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Knight KN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lac D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lexa KW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Liau NPD; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Becerra I; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Malfavon M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA., McInnes J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Nguyen HN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lozano EI; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Roche E; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Sacayon P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Calvert MEK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Daneman R; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA., Dennis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Duque J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Gadkar K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Mahon CS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Meisner R; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA., Watts RJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Zuchero YJY; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. zuchero@dnli.com., Kariolis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. kariolis@dnli.com.
Publikováno v: Nature communications [Nat Commun] 2023 Sep 07; Vol. 14 (1), pp. 5516. Date of Electronic Publication: 2023 Sep 07.
Zobrazit plný text záznamu
6
Akademický článek
CD98hc is a target for brain delivery of biotherapeutics.
Autor: Chew KS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Wells RC; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Moshkforoush A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chan D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lechtenberg KJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tran HL; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chow J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Kim DJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Robles-Colmenares Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Srivastava DB; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tong RK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tong M; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Xa K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Yang A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Zhou Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Akkapeddi P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Annamalai L; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Bajc K; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA., Blanchette M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA., Cherf GM; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Gill A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Huynh D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Joy D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Knight KN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lac D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lexa KW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Liau NPD; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Becerra I; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Malfavon M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA., McInnes J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Nguyen HN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lozano EI; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Roche E; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Sacayon P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Calvert MEK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Daneman R; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA., Dennis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Duque J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Gadkar K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Mahon CS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Meisner R; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA., Watts RJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Zuchero YJY; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. zuchero@dnli.com., Kariolis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. kariolis@dnli.com.
Publikováno v: Nature communications [Nat Commun] 2023 Aug 19; Vol. 14 (1), pp. 5053. Date of Electronic Publication: 2023 Aug 19.
Zobrazit plný text záznamu
7
Akademický článek
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice.
Autor: Ullman JC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Arguello A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Getz JA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bhalla A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Mahon CS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Wang J; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Giese T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bedard C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kim DJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Blumenfeld JR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Liang N; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Ravi R; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Nugent AA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Davis SS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Ha C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Duque J; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tran HL; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Wells RC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Lianoglou S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Daryani VM; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kwan W; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Solanoy H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Nguyen H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Earr T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dugas JC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tuck MD; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Harvey JL; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Reyzer ML; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Caprioli RM; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Hall S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Poda S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sanchez PE; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dennis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Gunasekaran K; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Srivastava A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sandmann T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Henne KR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Thorne RG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Di Paolo G; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Astarita G; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Diaz D; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Silverman AP; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Watts RJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sweeney ZK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kariolis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com henry@dnli.com., Henry AG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com henry@dnli.com.
Publikováno v: Science translational medicine [Sci Transl Med] 2020 May 27; Vol. 12 (545).
Zobrazit plný text záznamu
8
Akademický článek
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys.
Autor: Kariolis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com zuchero@dnli.com., Wells RC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Getz JA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kwan W; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Mahon CS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tong R; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kim DJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Srivastava A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bedard C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Henne KR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Giese T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Assimon VA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Chen X; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Zhang Y; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Solanoy H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Jenkins K; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sanchez PE; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kane L; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Miyamoto T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Chew KS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Pizzo ME; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Liang N; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Calvert MEK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., DeVos SL; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Baskaran S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Hall S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sweeney ZK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Thorne RG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Watts RJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dennis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Silverman AP; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Zuchero YJY; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com zuchero@dnli.com.
Publikováno v: Science translational medicine [Sci Transl Med] 2020 May 27; Vol. 12 (545).
Zobrazit plný text záznamu
9
Akademický článek
The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation.
Autor: Morris VA; Department of Microbiology, University of Washington, Seattle, WA, USA., Punjabi AS, Wells RC, Wittkopp CJ, Vart R, Lagunoff M
Publikováno v: Virology [Virology] 2012 Jul 05; Vol. 428 (2), pp. 112-20. Date of Electronic Publication: 2012 Apr 21.
Zobrazit plný text záznamu
10
Akademický článek
The C. elegans B-cell lymphoma 2 (Bcl-2) homolog cell death abnormal 9 (CED-9) associates with and remodels LIPID membranes.
Autor: Tan FJ; Department of Biology, Johns Hopkins University, Baltimore, Maryland 21218, USA., Zuckerman JE, Wells RC, Hill RB
Publikováno v: Protein science : a publication of the Protein Society [Protein Sci] 2011 Jan; Vol. 20 (1), pp. 62-74.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje